INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE STUDY LIBRARY

Narrative review / 2003

A review discusses the potential mechanism linking milk-derived beta-casomorphin to apnea in sudden infant death syndrome.

This review summarizes findings on the possible relationship between beta-casomorphin (beta-CM) and apnea in sudden infant death syndrome (SIDS). Beta-CM is an exogenous bioactive peptide derived from casein in milk with opioid activity. The authors discuss how circulating beta-CM might cross the immature blood-brain barrier and inhibit the brainstem respiratory center, potentially leading to apnea.

Shows an association, not proof of cause and effect.

Study type
Narrative review
Who was studied
Infants (context of SIDS)
What was measured
Possible association of beta-casomorphin to apnea in SIDS

THE PAPER

Relation of beta-casomorphin to apnea in sudden infant death syndrome.

Sun Z, Zhang Z, Wang X, Cade R, Elmir Z, Fregly M. Peptides, 2003.

PubMed 12948848 ↗DOI 10.1016/s0196-9781(03)00156-6 ↗

Brain & moodOther health

This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.